Clinical Trial Update: Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial) [NA]

View source ↗

Summary

The PeRFormanCe trial is exploring diffusion-weighted MRI, radiomics, and liquid biopsy to predict surgical resectability after FOLFIRINOX in border-line resect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Resectable Pancreatic Cancer
• Pancreatic Cancer

Drugs mentioned

• FOLFIRINOX

Snippet

Sponsor: University Hospital, Ghent | Conditions: Pancreatic Cancer | NA | Status: RECRUITING